Literature DB >> 15113910

Cellular RNA helicase p68 relocalization and interaction with the hepatitis C virus (HCV) NS5B protein and the potential role of p68 in HCV RNA replication.

Phuay-Yee Goh1, Yee-Joo Tan, Siew Pheng Lim, Y H Tan, Seng Gee Lim, Frances Fuller-Pace, Wanjin Hong.   

Abstract

Chronic infection by hepatitis C virus (HCV) can lead to severe hepatitis and cirrhosis and is closely associated with hepatocellular carcinoma. The replication cycle of HCV is poorly understood but is likely to involve interaction with host factors. In this report, we show that NS5B, the HCV RNA-dependent RNA polymerase (RdRp), interacts with a human RNA helicase, p68. Transient expression of NS5B alone, as well as the stable expression of all the nonstructural proteins in a HCV replicon-bearing cell line (V. Lohmann, F. Korner, J.-O. Koch, U. Herian, L. Theilmann, and R. Bartenschlager, Science 285:110-113), causes the redistribution of endogenous p68 from the nucleus to the cytoplasm. Deletion of the C-terminal two-thirds of NS5B (NS5BDeltaC) dramatically reduces its coimmunoprecipitation (co-IP) with endogenous p68, while the deletion of the N-terminal region (NS5BDeltaN1 and NS5BDeltaN2) does not affect its interaction with p68. In consistency with the co-IP results, NS5BDeltaC does not cause the relocalization of p68 whereas NS5BDeltaN1 does. With a replicon cell line, we were not able to detect a change in positive- and negative-strand synthesis when p68 levels were reduced using small interfering RNA (siRNA). In cells transiently transfected with a full-length HCV construct, however, the depletion (using specific p68 siRNA) of endogenous p68 correlated with a reduction in the transcription of negative-strand from positive-strand HCV RNA. Overexpression of NS5B and NS5BDeltaN1, but not that of NS5BDeltaC, causes a reduction in the negative-strand synthesis, indicating that overexpressed NS5B and NS5BDeltaN1 sequesters p68 from the replication complexes (thus reducing their replication activity levels). Identification of p68 as a cellular factor involved in HCV replication, at least for cells transiently transfected with a HCV expression construct, is a step towards understanding HCV replication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15113910      PMCID: PMC400326          DOI: 10.1128/jvi.78.10.5288-5298.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

Review 1.  Cell-based and animal models for hepatitis B and C viruses.

Authors:  R F Schinazi; E Ilan; P L Black; X Yao; S Dagan
Journal:  Antivir Chem Chemother       Date:  1999-05

2.  Mutations that affect dimer formation and helicase activity of the hepatitis C virus helicase.

Authors:  Y L Khu; E Koh; S P Lim; Y H Tan; S Brenner; S G Lim; W J Hong; P Y Goh
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  Identification and molecular characterisation of the complete genome of a Singapore isolate of hepatitis C virus: sequence comparison with other strains and phylogenetic analysis.

Authors:  S P Lim; Y L Khu; W J Hong; A Tay; A E Ting; S G Lim; Y H Tan
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

4.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

5.  A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA.

Authors:  M Watanabe; J Yanagisawa; H Kitagawa; K Takeyama ; S Ogawa; Y Arao; M Suzawa; Y Kobayashi; T Yano; H Yoshikawa; Y Masuhiro; S Kato
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

Review 6.  Novel cell culture systems for the hepatitis C virus.

Authors:  R Bartenschlager; V Lohmann
Journal:  Antiviral Res       Date:  2001-10       Impact factor: 5.970

7.  Absence of Dbp2p alters both nonsense-mediated mRNA decay and rRNA processing.

Authors:  A T Bond; D A Mangus; F He; A Jacobson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

8.  Characterization of cell lines carrying self-replicating hepatitis C virus RNAs.

Authors:  T Pietschmann; V Lohmann; G Rutter; K Kurpanek; R Bartenschlager
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

9.  Efficient initiation of HCV RNA replication in cell culture.

Authors:  K J Blight; A A Kolykhalov; C M Rice
Journal:  Science       Date:  2000-12-08       Impact factor: 47.728

10.  Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein.

Authors:  H Tu; L Gao; S T Shi; D R Taylor; T Yang; A K Mircheff; Y Wen; A E Gorbalenya; S B Hwang; M M Lai
Journal:  Virology       Date:  1999-10-10       Impact factor: 3.616

View more
  56 in total

Review 1.  RNA helicases: emerging roles in viral replication and the host innate response.

Authors:  Arnaz Ranji; Kathleen Boris-Lawrie
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

2.  Unlocking the DEAD-box: a key to cryptococcal virulence?

Authors:  Lena J Heung; Maurizio Del Poeta
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

3.  The Epstein-Barr virus replication protein BBLF2/3 provides an origin-tethering function through interaction with the zinc finger DNA binding protein ZBRK1 and the KAP-1 corepressor.

Authors:  Gangling Liao; Jian Huang; Elizabeth D Fixman; S Diane Hayward
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 4.  New therapeutic opportunities for hepatitis C based on small RNA.

Authors:  Qiu-Wei Pan; Scot D Henry; Bob J Scholte; Hugo W Tilanus; Harry L A Janssen; Luc J W van der Laan
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

Review 5.  Understanding the interaction of hepatitis C virus with host DEAD-box RNA helicases.

Authors:  Megha Haridas Upadya; Jude Juventus Aweya; Yee-Joo Tan
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

6.  Expression, purification and preliminary crystallographic analysis of recombinant human DEAD-box polypeptide 5.

Authors:  Yook Wah Choi; Sujit Dutta; Burtram C Fielding; Yee Joo Tan
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-01-28

7.  Stem-loop recognition by DDX17 facilitates miRNA processing and antiviral defense.

Authors:  Ryan H Moy; Brian S Cole; Ari Yasunaga; Beth Gold; Ganesh Shankarling; Andrew Varble; Jerome M Molleston; Benjamin R tenOever; Kristen W Lynch; Sara Cherry
Journal:  Cell       Date:  2014-08-14       Impact factor: 41.582

8.  The Hepatitis C Virus NS5A Stimulates NS5B During In Vitro RNA Synthesis in a Template Specific Manner.

Authors:  Elizabeth M Quezada; Caroline M Kane
Journal:  Open Biochem J       Date:  2009-04-20

Review 9.  Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer.

Authors:  David R McGivern; Stanley M Lemon
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

10.  P68 RNA helicase is a nucleocytoplasmic shuttling protein.

Authors:  Haizhen Wang; Xueliang Gao; Yun Huang; Jenny Yang; Zhi-Ren Liu
Journal:  Cell Res       Date:  2009-09-29       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.